{"id":276523,"date":"2026-09-29T10:33:03","date_gmt":"2026-09-29T05:03:03","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=276523"},"modified":"2026-09-29T10:33:03","modified_gmt":"2026-09-29T05:03:03","slug":"why-glaxosmithkline-pharmaceuticals-share-price-price-fall-2026-09-29","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-share-price-price-fall-2026-09-29\/","title":{"rendered":"Glaxosmithkline Pharmaceuticals (GLAXO) Share Price Falls 2.22% Today"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/glaxo\/glaxosmithkline-pharmaceuticals-ltd-share-price-today\">Glaxosmithkline Pharmaceuticals (GLAXO)<\/a> share price fell to Rs 2,833.65 today, down 2.22% from the previous close. Market cap was Rs 47,719.14 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong>&nbsp;&nbsp;&nbsp;29 September 2026 at 10:23:29 AM IST<\/p>\n<p style=\"margin-top:0!important;\">Glaxosmithkline Pharmaceuticals Share Price fell to Rs 2,833.65 on 29 September 2026, down 2.22% from the previous close, with the company valued at Rs 47,719.14 crore in market capitalisation. The move places GLAXO back in focus for Glaxosmithkline Pharmaceuticals Share Price Today searches, especially because the day\u2019s data confirms a clear decline but does not establish any company-specific catalyst. In GLAXO Stock News today, the verified figures show a gap between the opening price and the day\u2019s closing level, while the market-cap category remains Large Cap. For readers tracking Glaxosmithkline Pharmaceuticals Share Price News, the relevant question is not only what changed in price, but also how the current valuation, sector benchmark and peer set compare with this level.<\/p>\n<p>Univest is covering the stock as part of its live market coverage, and the data available here supports a factual Glaxosmithkline Pharmaceuticals Share Price update rather than a reasoned event narrative. The stock\u2019s movement is best read through today\u2019s price action, its fundamentals and the broader healthcare context.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-share-price-price-fall-2026-09-29\/#Glaxosmithkline_Pharmaceuticals_GLAXO_Share_Price_Today_Price_Action_Analysis\" title=\"Glaxosmithkline Pharmaceuticals (GLAXO) Share Price Today: Price Action Analysis\">Glaxosmithkline Pharmaceuticals (GLAXO) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-share-price-price-fall-2026-09-29\/#Glaxosmithkline_Pharmaceuticals_GLAXO_Fundamental_Analysis\" title=\"Glaxosmithkline Pharmaceuticals (GLAXO) Fundamental Analysis\">Glaxosmithkline Pharmaceuticals (GLAXO) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-share-price-price-fall-2026-09-29\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-share-price-price-fall-2026-09-29\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-share-price-price-fall-2026-09-29\/#Why_Investors_Are_Watching_Glaxosmithkline_Pharmaceuticals\" title=\"Why Investors Are Watching Glaxosmithkline Pharmaceuticals\">Why Investors Are Watching Glaxosmithkline Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-share-price-price-fall-2026-09-29\/#About_Glaxosmithkline_Pharmaceuticals\" title=\"About Glaxosmithkline Pharmaceuticals\">About Glaxosmithkline Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-share-price-price-fall-2026-09-29\/#Track_Glaxosmithkline_Pharmaceuticals_Share_Price_on_Univest\" title=\"Track Glaxosmithkline Pharmaceuticals Share Price on Univest\">Track Glaxosmithkline Pharmaceuticals Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-share-price-price-fall-2026-09-29\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-share-price-price-fall-2026-09-29\/#Why_did_Glaxosmithkline_Pharmaceuticals_Share_Price_fall_today\" title=\"Why did Glaxosmithkline Pharmaceuticals Share Price fall today?\">Why did Glaxosmithkline Pharmaceuticals Share Price fall today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-share-price-price-fall-2026-09-29\/#What_is_Glaxosmithkline_Pharmaceuticals_Share_Price_today\" title=\"What is Glaxosmithkline Pharmaceuticals Share Price today?\">What is Glaxosmithkline Pharmaceuticals Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-share-price-price-fall-2026-09-29\/#How_much_did_GLAXO_fall_in_todays_trade\" title=\"How much did GLAXO fall in today\u2019s trade?\">How much did GLAXO fall in today\u2019s trade?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-share-price-price-fall-2026-09-29\/#What_is_the_market_capitalisation_of_Glaxosmithkline_Pharmaceuticals\" title=\"What is the market capitalisation of Glaxosmithkline Pharmaceuticals?\">What is the market capitalisation of Glaxosmithkline Pharmaceuticals?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-share-price-price-fall-2026-09-29\/#How_do_GLAXO_valuation_metrics_compare_with_the_healthcare_sector\" title=\"How do GLAXO valuation metrics compare with the healthcare sector?\">How do GLAXO valuation metrics compare with the healthcare sector?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Glaxosmithkline_Pharmaceuticals_GLAXO_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Glaxosmithkline Pharmaceuticals (GLAXO) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,833.65<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,897.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 64.20 (-2.22%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,880.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,893.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,833.65<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.3 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 47,719.14 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Glaxosmithkline Pharmaceuticals Share Price Today opened at Rs 2,880.05, moved between a day high of Rs 2,893.70 and a day low of Rs 2,833.65, and ended at Rs 2,833.65. That is a day change of Rs -64.20, or -2.22%, versus the previous close of Rs 2,897.85. The stock\u2019s turnover stood at Rs 0.3 crore. The price action shows that the day\u2019s low matched the closing price, which is useful context for readers following GLAXO Share Price Live and Glaxosmithkline Pharmaceuticals Share Price Update pages.<\/p>\n<p>With a market capitalisation of Rs 47,719.14 crore, the company sits in the Large Cap category. For Glaxosmithkline Pharmaceuticals Share Price watchers, the key factual takeaway is that today\u2019s trade ended below both the open and the previous close, while the published numbers confirm the decline without identifying a company-specific reason. In GLAXO Share Price News, this is a clean same-day fall that should be read alongside the company\u2019s valuation and healthcare industry context. That sets up the next question: what do the financial metrics and sector comparisons say about the stock\u2019s current standing?<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Glaxosmithkline_Pharmaceuticals_GLAXO_Fundamental_Analysis\"><\/span><strong>Glaxosmithkline Pharmaceuticals (GLAXO) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 47,719.14 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">45.96x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">19.48x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.76%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">66.79%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 63.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 148.77<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.97%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Glaxosmithkline Pharmaceuticals Share Price today must be read with its valuation profile. The stock trades at a price-to-earnings ratio of 45.96 and a price-to-book ratio of 19.48, both well above many large listed names and also above the industry medians shown later in this article. For investors following GLAXO Share Price News or Glaxosmithkline Pharmaceuticals Fundamental Analysis, those multiples indicate that the market is assigning a substantial premium to each unit of earnings and book value.<\/p>\n<p>The company\u2019s return on equity is 48.76% and return on capital employed is 66.79%, which are strong absolute profitability measures. Earnings per share stands at Rs 63.05, book value per share is Rs 148.77, and dividend yield is 1.97%. Those figures matter because EPS reflects earnings attributable to each share, book value per share shows accounting net worth behind each share, and dividend yield reflects historical payout relative to the current Glaxosmithkline Pharmaceuticals Share Price. With no fresh catalyst in the supplied data, the fundamentals provide the main context for understanding why the stock remains closely watched in GLAXO Stock News and Glaxosmithkline Pharmaceuticals Stock Analysis.<\/p>\n<p>From a company-level perspective, the market-cap figure of Rs 47,719.14 crore places the business among the larger names in the healthcare universe, and the valuation metrics suggest that investors are already attaching a significant premium to the stock relative to earnings and net asset value. That naturally leads to ownership, sector and peer context, which offer a fuller picture for anyone tracking Glaxosmithkline Pharmaceuticals Share Price Today.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">45.96x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.59x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.46x to 707.31x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">19.48x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.88x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.34x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.76%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.68%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">66.79%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.61%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 47,719.14 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 783.26 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,389.26 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Glaxosmithkline Pharmaceuticals operates in Healthcare, within Pharmaceuticals &amp; Drugs, and the benchmark scope supplied here is the same industry across 199 companies. In that set, the company\u2019s P\/E of 45.96 sits above the sector median of 32.59 but below the sector average of 49. Its P\/B of 19.48 is also well above the sector median of 2.88 and the sector average of 4.34. That comparison matters for Glaxosmithkline Pharmaceuticals Share Price because it shows the stock is valued at a richer level than the typical industry name on both earnings and book-value measures.<\/p>\n<p>The same industry benchmark also shows company ROE of 48.76% versus a median of 11.7% and average of 10.68%, while ROCE of 66.79% is above the median of 13.61% and average of 13.4%. In market-cap terms, the industry median is Rs 783.26 crore and the average is Rs 14,389.26 crore, whereas GLAXO\u2019s market capitalisation is Rs 47,719.14 crore. That places the company well above the industry midpoint on size. For readers searching Glaxosmithkline Pharmaceuticals Share Price Fall or Glaxosmithkline Pharmaceuticals Stock News Today, the important point is that today\u2019s decline occurred against a background of premium valuation and strong reported returns, not against weak operating-return figures in the supplied dataset.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,44,716.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">36.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.1<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,55,115.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">86.51<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,89,613.38<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">84.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.64<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,19,899.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.79<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,12,875.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.29<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Among the supplied peers, Glaxosmithkline Pharmaceuticals Share Price sits in a compact but high-valued part of the healthcare universe. Its P\/E of 45.96 is higher than Sun Pharmaceutical Industries at 36.5, Cipla at 33.29, Dr. Reddy\u2019s Laboratories at 31.67 and Zydus Lifesciences at 26.79, but lower than Divi\u2019s Laboratories at 86.51, Torrent Pharmaceuticals at 84.92, Laurus Labs at 99.43 and slightly below Mankind Pharma at 49.33.<\/p>\n<p>On return ratios, GLAXO\u2019s ROE of 48.76% and ROCE of 66.79% are above the values shown for every peer in the supplied list, including Lupin at 27.11% ROE and 28.86% ROCE. Its market capitalisation of Rs 47,719.14 crore is below Sun Pharma and the larger peers such as Divi\u2019s and Torrent, but above several other listed names in the set. For Glaxosmithkline Pharmaceuticals Share Price Today analysis, that means the stock combines a sizable market value with unusually strong return metrics relative to the peer sample, even though today\u2019s price action was negative.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Glaxosmithkline_Pharmaceuticals\"><\/span><strong>Why Investors Are Watching Glaxosmithkline Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Glaxosmithkline Pharmaceuticals Share Price fell 2.22% today to Rs 2,833.65.<\/li>\n<li>The stock closed below the previous close of Rs 2,897.85 after opening at Rs 2,880.05.<\/li>\n<li>Day high was Rs 2,893.70 and day low was Rs 2,833.65.<\/li>\n<li>Market capitalisation stands at Rs 47,719.14 crore, and the company is in the Large Cap category.<\/li>\n<li>P\/E of 45.96, P\/B of 19.48, ROE of 48.76% and ROCE of 66.79% frame the current GLAXO Share Price story.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Glaxosmithkline_Pharmaceuticals\"><\/span><strong>About Glaxosmithkline Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Glaxosmithkline Pharmaceuticals operates in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. The company sits within a large listed healthcare peer group and is tracked by investors who follow GLAXO Share Price Today, Glaxosmithkline Pharmaceuticals Stock News and Glaxosmithkline Pharmaceuticals Share Price News. Its supplied market context centres on valuation, returns and industry comparison rather than a company narrative built around unstated business details.<\/p>\n<p>For readers scanning Glaxosmithkline Pharmaceuticals Share Price and GLAXO News Today, the relevant company facts are its market capitalisation, valuation multiples, profitability ratios, earnings per share, book value and dividend yield. Those metrics are enough to place the stock within the healthcare sector without adding assumptions beyond the supplied data.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Glaxosmithkline_Pharmaceuticals_Share_Price_on_Univest\"><\/span><strong>Track Glaxosmithkline Pharmaceuticals Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use&nbsp;<a href=\"https:\/\/univest.in\/stocks\/glaxo\/glaxosmithkline-pharmaceuticals-ltd-share-price-today\">Glaxosmithkline Pharmaceuticals (GLAXO) live share-price page<\/a>,<a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>,<a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top decliners and related market analysis.<\/p>\n<p>Track Glaxosmithkline Pharmaceuticals Share Price on Univest for live updates, market cap, valuation ratios, shareholding pattern, 52-week levels and company market insights. Univest also brings together GLAXO Share Price Live, fundamental ratios and sector comparison in one place for faster stock news tracking.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong>&nbsp;&nbsp;Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Glaxosmithkline_Pharmaceuticals_Share_Price_fall_today\"><\/span><strong>Why did Glaxosmithkline Pharmaceuticals Share Price fall today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;The supplied data confirms that Glaxosmithkline Pharmaceuticals Share Price fell 2.22% to Rs 2,833.65, but it does not establish a company-specific catalyst. The move is best read through today\u2019s price action and valuation context.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Glaxosmithkline_Pharmaceuticals_Share_Price_today\"><\/span><strong>What is Glaxosmithkline Pharmaceuticals Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Glaxosmithkline Pharmaceuticals Share Price today is Rs 2,833.65. The stock declined from the previous close of Rs 2,897.85, and the day\u2019s range ran from Rs 2,833.65 to Rs 2,893.70.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_GLAXO_fall_in_todays_trade\"><\/span><strong>How much did GLAXO fall in today\u2019s trade?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;GLAXO fell Rs -64.20, which equals -2.22% versus the previous close. The opening price was Rs 2,880.05, so the stock stayed below both the open and the prior close by the end of the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Glaxosmithkline_Pharmaceuticals\"><\/span><strong>What is the market capitalisation of Glaxosmithkline Pharmaceuticals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;The company\u2019s market capitalisation is Rs 47,719.14 crore. That places it in the Large Cap category and well above the industry median market capitalisation of Rs 783.26 crore within the same industry benchmark.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_do_GLAXO_valuation_metrics_compare_with_the_healthcare_sector\"><\/span><strong>How do GLAXO valuation metrics compare with the healthcare sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;GLAXO trades at 45.96 times earnings and 19.48 times book value. Those are above the industry median P\/E of 32.59 and P\/B of 2.88, while its ROE and ROCE are also above the benchmark median.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Glaxosmithkline Pharmaceuticals Share Price falls to Rs 2,833.65. marking a 2.22% fall today. Market cap stands at Rs 47,719.14 crore.<\/p>\n","protected":false},"author":29,"featured_media":276522,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-276523","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["276522"],"rank_math_title":["Glaxosmithkline Pharmaceuticals Share Price Falls 2.22%"],"rank_math_description":["Glaxosmithkline Pharmaceuticals Share Price fell 2.22% to Rs 2,833.65. Read today\u2019s price action, valuation, sector and peer context."],"rank_math_focus_keyword":["Glaxosmithkline Pharmaceuticals Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/glaxosmithkline-pharmaceuticals-glaxo-share-price-falls-2-22-today.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/276523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=276523"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/276523\/revisions"}],"predecessor-version":[{"id":276525,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/276523\/revisions\/276525"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/276522"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=276523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=276523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=276523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}